Table 3.
When to Prefer Triple Therapy FDCs Over Dual Bronchodilation
Immediate choice in |
• Patients who present for the first time, and have severe airway obstruction (FEV1 <50%) and are symptomatic |
• Patients who have had frequent (≥2) moderate or severe exacerbations (≥1 hospitalisation) in the previous year |
• Patients who have peripheral eosinophilia (>300 cells·μL−1) |
• Patients with significant lung function decline |
• Patients discharged from hospital after a COPD exacerbation. |